Charles A. Rowland Jr., Director at Blueprint Medicines Corp (BPMC), sold 21,818 shares at $117.82 ($2.6M) on 2020-12-17, disclosed to the SEC on 2020-12-18.
Open-market sale of $2.6M BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.82 | 10,909 | $1.3M | 50.0% |
| 2 | $117.82 | 10,909 | $1.3M | 50.0% |
| Total | $117.82 avg | 21,818 | $2.6M | 100% |
| Filing → |
| VKTX | SELL | 2023-05-18 | $1.0M | — | Filing → |
| GBIO | BUY | 2022-09-20 | $83K | — | Filing → |
| GBIO | BUY | 2022-09-19 | $552K | — | Filing → |